I’m with you Doc, Hopefully the company has something lined up to temper this disappointment. A MHRA Sawston Certification or clinicaltrials.gov update would sure be nice ;) I mean throw retail a bone LP! It sure would be tough if we got a sell off due to no ASCO abstract and no publication until July... but in terms of NWBOs playbook, I think they could care less about the price action between now and publication. I guess at worst it’s another “buying opportunity” and at best we run-up as publication gets closer.
Market Data 
Markets 
AI
